Meropenem was provided as unreconstituted drug in the ADD-Vantage, Minibag Plus (Baxter Healthcare), and addEASE (McGaw) infusion systems.

A study published in the European Journal of Pediatrics reveals alarming rates of antibiotic resistance affecting neonatal ...

Meropenem with vaborbactam (Vaborem, Menarini) is a combination of a broad-spectrum carbapenem antibiotic, which covers gram-positive, gram-negative and anaerobic bacteria, and a new beta-lactamase ...

Meropenem is a carbapenem antibiotic that appears to be widely distributed in tissues and is eliminated by both excretion and metabolism. Approximately 70% of meropenem is excreted via the kidneys, ...

Meropenem(Merrem IV) generic is a carbapenem antibiotic, prescribed for bacterial infections like skin and skin structure infections, bacterial meningitis, ...

Meropenem and vaborbactam combination should not be used in patients with- • Hypersensitivity to meropenem and vaborbactam or any other β-lactams • Viral Infections such as common cold or flu ...

Meropenem with vaborbactam is a new antimicrobial and therefore data on resistance and the impact in clinical practice in the UK are limited. Person-related factors Meropenem with vaborbactam is ...

Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Meropenem Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Sales revenue of Meropenem in ...

Cefepime–taniborbactam was superior to meropenem regarding the primary outcome (treatment difference, 12.6 percentage points; 95% confidence interval, 3.1 to 22.2; P=0.009).

Meropenem has been approved by the Food and Drug Administration (FDA) for the treatment of abdominal infections in infants <3 months old.. The approval was based on an open-label, multiple-dose ...